doi: 10.1055/s-2008-1053590.
[Chemotherapy in malignant gliomas]
[Article in
German]
Affiliations
- PMID: 2293042
- DOI: 10.1055/s-2008-1053590
Item in Clipboard
[Chemotherapy in malignant gliomas]
[Article in
German]
Neurochirurgia (Stuttg).
1990 Oct.
Abstract
Considering the survival time of patients with malignant gliomas indication for chemotherapy in spite of side effects is recommended. One third of them are living 2 years, some even longer. Before starting such a treatment a critical evaluation is mandatory, a prolongation of dying must be avoided. In addition personal human care to the patient and his family has a great importance.
Similar articles
-
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].Rev Neurol (Paris). 1979 Mar;135(3):251-62. Rev Neurol (Paris). 1979. PMID: 227020 French. No abstract available.
-
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.J Clin Oncol. 2003 Sep 1;21(17):3276-84. doi: 10.1200/JCO.2003.03.509. J Clin Oncol. 2003. PMID: 12947063 Clinical Trial.
-
Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):390-6. doi: 10.1016/j.ijrobp.2007.03.003. Epub 2007 Apr 24. Int J Radiat Oncol Biol Phys. 2007. PMID: 17459607 Clinical Trial.
-
Chemotherapy in the treatment of malignant gliomas.Expert Rev Anticancer Ther. 2006 May;6(5):755-67. doi: 10.1586/14737140.6.5.755. Expert Rev Anticancer Ther. 2006. PMID: 16759165 Review.
-
[Chemotherapy of brain tumors].Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:377-83. Gan To Kagaku Ryoho. 1994. PMID: 7986118 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical